SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Apr-24 5:09 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Apr-24 | Grant | 1,000 | $2.84 | $2,840.00 | 18% 5.68K to 6.68K | |
05-Feb-24 5:52 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Feb-24 | Payment of Exercise | 202 | $3.01 | $608.02 | (3%) 5.88K to 5.68K | |
03-Feb-23 5:04 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Feb-23 | Grant | 1,000 | $3.52 | $3,520.00 | 22% 4.49K to 5.49K | |
03-Feb-23 5:04 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Feb-23 | Payment of Exercise | 104 | $3.52 | $366.08 | (2%) 5.49K to 5.38K | |
03-Feb-22 4:37 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Feb-22 | Grant | 1,000 | $10.02 | $10,020.00 | 33% 3.04K to 4.04K | |
03-Feb-22 4:37 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Feb-22 | Payment of Exercise | 52 | $10.02 | $521.04 | (1%) 4.04K to 3.98K | |
13-Aug-21 4:32 PM View: | Lumos Pharma, Inc. (LUMO) | 12-Aug-21 | Market Purchase | 1,700 | $7.42 | $12,614.00 | 127% 1.34K to 3.04K | 6% |
13-Aug-21 4:32 PM View: | Lumos Pharma, Inc. (LUMO) | 11-Aug-21 | Market Purchase | 300 | $7.35 | $2,205.00 | 29% 1.04K to 1.34K | 7% |
28-Sep-18 5:11 PM View: | Spyre Therapeutics, Inc. (SYRE) | 27-Sep-18 | Market Sale | 6,000 | $9.50 | $57,005.00 | (71%) 8.5K to 2.5K | 12% |
21-Aug-18 4:24 PM View: | Spyre Therapeutics, Inc. (SYRE) | 17-Aug-18 | Option Exercise | 8,500 | $3.50 | $29,750.00 | 100% 0 to 8.5K |